Process View
The network for 'regulation of vasculature development' in your query organism is displayed on the left, if relationships are supported by the integrated data. Moving any of the genes in that network will simultaneously update the homologs in the networks displayed to the right (if they exist). Additionally, hovering over any nodes will highlight the identified functionally similar homologs in the other networks. Last, the bar above the networks allows you to remove/add additional organisms. Simily drag and drop the organism names in the desired order.
Any process that modulates the frequency, rate or extent of vasculature development.
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.970 | |
TEK | TEK tyrosine kinase, endothelial | 0.946 | |
SKIL | SKI-like oncogene | 0.930 | |
FGFR2 | fibroblast growth factor receptor 2 | 0.922 | |
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.914 | |
JAG1 | jagged 1 | 0.912 | |
VEGFA | vascular endothelial growth factor A | 0.906 | |
NOTCH1 | notch 1 | 0.897 | |
LAT | linker for activation of T cells | 0.880 | |
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.871 | |
CCR5 | chemokine (C-C motif) receptor 5 | 0.859 | |
YAP1 | Yes-associated protein 1 | 0.839 | |
ENG | endoglin | 0.819 | |
CAV2 | caveolin 2 | 0.810 | |
IL8 | interleukin 8 | 0.774 | |
CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.728 | |
CREBBP | CREB binding protein | 0.714 | |
MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.686 | |
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.685 | |
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.684 | |
TAL1 | T-cell acute lymphocytic leukemia 1 | 0.681 | |
HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.667 | |
DUSP1 | dual specificity phosphatase 1 | 0.643 | |
TGFB1 | transforming growth factor, beta 1 | 0.627 | |
IL2RB | interleukin 2 receptor, beta | 0.614 | |
FGFR1 | fibroblast growth factor receptor 1 | 0.586 | |
EFNA1 | ephrin-A1 | 0.565 | |
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.559 | |
CD34 | CD34 molecule | 0.554 | |
YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide | 0.524 | |
NRP1 | neuropilin 1 | 0.521 | |
HSPB8 | heat shock 22kDa protein 8 | 0.512 | |
CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.506 | |
HTT | huntingtin | 0.504 | |
RUNX1 | runt-related transcription factor 1 | 0.497 | |
CALM1 | calmodulin 1 (phosphorylase kinase, delta) | 0.492 | |
PLAUR | plasminogen activator, urokinase receptor | 0.492 | |
PLAU | plasminogen activator, urokinase | 0.488 | |
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.486 | |
XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 0.480 | |
FGB | fibrinogen beta chain | 0.478 | |
RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.470 | |
PML | promyelocytic leukemia | 0.464 | |
CCL2 | chemokine (C-C motif) ligand 2 | 0.463 | |
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.463 | |
COL4A2 | collagen, type IV, alpha 2 | 0.452 | |
BCL6 | B-cell CLL/lymphoma 6 | 0.444 | |
FGA | fibrinogen alpha chain | 0.440 | |
TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.429 | |
EPAS1 | endothelial PAS domain protein 1 | 0.421 | |
FAS | Fas (TNF receptor superfamily, member 6) | 0.406 | |
CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.398 | |
ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.384 | |
PBX1 | pre-B-cell leukemia homeobox 1 | 0.381 | |
NID1 | nidogen 1 | 0.375 | |
YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.367 | |
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.364 | |
VEGFC | vascular endothelial growth factor C | 0.360 | |
CCR2 | chemokine (C-C motif) receptor 2 | 0.359 | |
MEF2C | myocyte enhancer factor 2C | 0.339 | |
SMAD3 | SMAD family member 3 | 0.336 | |
SMAD2 | SMAD family member 2 | 0.335 | |
CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.333 | |
HOXB5 | homeobox B5 | 0.319 | |
TNFRSF6B | tumor necrosis factor receptor superfamily, member 6b, decoy | 0.308 | |
COL1A1 | collagen, type I, alpha 1 | 0.306 | |
CCL5 | chemokine (C-C motif) ligand 5 | 0.306 | |
YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.299 | |
IL1B | interleukin 1, beta | 0.298 | |
PPL | periplakin | 0.294 | |
CRYAB | crystallin, alpha B | 0.293 | |
NOTCH3 | notch 3 | 0.290 | |
FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.290 | |
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.289 | |
COL4A1 | collagen, type IV, alpha 1 | 0.289 | |
TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.289 | |
IRF9 | interferon regulatory factor 9 | 0.284 | |
CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.282 | |
FSTL1 | follistatin-like 1 | 0.272 | |
EP300 | E1A binding protein p300 | 0.268 | |
IFNG | interferon, gamma | 0.258 | |
PDGFC | platelet derived growth factor C | 0.256 | |
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.251 | |
VCAM1 | vascular cell adhesion molecule 1 | 0.250 | |
CD44 | CD44 molecule (Indian blood group) | 0.245 | |
BMPR1B | bone morphogenetic protein receptor, type IB | 0.244 | |
BMPR1A | bone morphogenetic protein receptor, type IA | 0.236 | |
CTGF | connective tissue growth factor | 0.234 | |
SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.231 | |
COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.228 | |
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.227 | |
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.219 | |
ANGPTL2 | angiopoietin-like 2 | 0.218 | |
PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.214 | |
PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.214 | |
PRKCD | protein kinase C, delta | 0.213 | |
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.210 | |
IL4R | interleukin 4 receptor | 0.210 | |
EGFR | epidermal growth factor receptor | 0.210 | |
RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.204 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
kdrl | kinase insert domain receptor like | 0.737 | |
notch3 | notch homolog 3 | 0.493 | |
krit1 | KRIT1, ankyrin repeat containing | 0.337 | |
ccm2 | cerebral cavernous malformation 2 | 0.336 | |
plcg1 | phospholipase C, gamma 1 | 0.319 | |
nrp1a | neuropilin 1a | 0.304 | |
fn1 | fibronectin 1 | 0.301 | |
cxcl12b | chemokine (C-X-C motif) ligand 12b (stromal cell-derived factor 1) | 0.249 | |
nrarpa | notch-regulated ankyrin repeat protein a | 0.248 | |
sox9a | SRY-box containing gene 9a | 0.248 | |
plxnd1 | plexin D1 | 0.219 | |
fbn2b | fibrillin 2b | 0.212 | |
dll4 | delta-like 4 (Drosophila) | 0.188 | |
etv2 | ets variant gene 2 | 0.179 | |
tie1 | endothelium-specific receptor tyrosine kinase 1 | 0.154 | |
col12a1 | collagen, type XII, alpha 1 | 0.148 | |
erg | v-ets erythroblastosis virus E26 oncogene like (avian) | 0.142 | |
kdr | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.139 | |
tal1 | T-cell acute lymphocytic leukemia 1 | 0.135 | |
vegfc | vascular endothelial growth factor c | 0.129 | |
thbs1 | thrombospondin 1 | 0.121 | |
cnn2 | calponin 2 | 0.112 | |
tpm4 | tropomyosin 4 | 0.108 | |
dlc | deltaC | 0.104 | |
agtr2 | angiotensin II receptor, type 2 | 0.102 | |
acvrl1 | activin A receptor type II-like 1 | 0.100 | |
wu:fv91b12 | wu:fv91b12 | 0.092 | |
vegfaa | vascular endothelial growth factor Aa | 0.092 | |
notch1b | notch homolog 1b | 0.091 | |
hs6st2 | heparan sulfate 6-O-sulfotransferase 2 | 0.087 | |
dlb | deltaB | 0.087 | |
tp63 | tumor protein p63 | 0.086 | |
mrc1a | mannose receptor, C type 1a | 0.086 | |
pcdh18b | protocadherin 18b | 0.084 | |
bty | bloodthirsty | 0.083 | |
col5a2l | collagen, type V, alpha 2-like | 0.082 | |
lama5 | laminin, alpha 5 | 0.079 | |
pax8 | paired box gene 8 | 0.077 | |
bmp2b | bone morphogenetic protein 2b | 0.076 | |
si:ch211-212m21.5 | si:ch211-212m21.5 | 0.074 | |
efnb2a | ephrin B2a | 0.072 | |
arhgef7b | Rho guanine nucleotide exchange factor (GEF) 7b | 0.071 | |
arap3 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 | 0.071 | |
sox2 | SRY-box containing gene 2 | 0.070 | |
wt1a | wilms tumor 1a | 0.067 | |
rxrbb | retinoid x receptor, beta b | 0.065 | |
cdh5 | cadherin 5 | 0.064 | |
flt4 | fms-related tyrosine kinase 4 | 0.063 | |
igf2b | insulin-like growth factor 2b | 0.060 | |
fras1 | Fraser syndrome 1 | 0.060 | |
egr2b | early growth response 2b | 0.058 | |
sulf2l | sulfatase 2, like | 0.058 | |
flt1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.058 | |
gli2a | GLI-Kruppel family member GLI2a | 0.057 | |
olig4 | oligodendrocyte transcription factor 4 | 0.057 | |
tie2 | endothelium-specific receptor tyrosine kinase 2 | 0.057 | |
mmp2 | matrix metalloproteinase 2 | 0.056 | |
ednra | endothelin receptor type A | 0.056 | |
tbx20 | T-box 20 | 0.056 | |
mcamb | melanoma cell adhesion molecule b | 0.055 | |
tagln2 | transgelin 2 | 0.055 | |
selp | selectin P | 0.055 | |
otpb | orthopedia homolog b | 0.055 | |
egr1 | early growth response 1 | 0.054 | |
ephb4a | eph receptor B4a | 0.054 | |
isl1 | islet1 | 0.053 | |
jag1b | jagged 1b | 0.052 | |
plod1a | procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1a | 0.051 | |
sulf2 | sulfatase 2 | 0.051 | |
nphs1l | nephrosis 1, congenital, Finnish type (nephrin)-like | 0.051 | |
hand2 | heart and neural crest derivatives expressed transcript 2 | 0.050 | |
hey1 | hairy/enhancer-of-split related with YRPW motif 1 | 0.050 | |
hspa12b | heat shock protein 12B | 0.049 | |
pdgfrl | platelet-derived growth factor receptor-like | 0.049 | |
prdm16 | PR domain containing 16 | 0.048 | |
nf1a | neurofibromin 1a | 0.047 | |
calcrla | calcitonin receptor-like a | 0.046 | |
itga5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.045 | |
trpv6 | transient receptor potential cation channel, subfamily V, member 6 | 0.044 | |
hlxb9lb | homeo box HB9 like b | 0.044 | |
zgc:64042 | zgc:64042 | 0.044 | |
insm1b | insulinoma-associated 1b | 0.043 | |
postn | periostin, osteoblast specific factor | 0.043 | |
ilk | integrin linked kinase | 0.043 | |
podxl | podocalyxin-like | 0.043 | |
cdon | cell adhesion molecule-related/down-regulated by oncogenes | 0.043 | |
nf1b | neurofibromin 1b | 0.041 | |
osr2 | odd-skipped related 2 (Drosophila) | 0.040 | |
atoh8 | atonal homolog 8 | 0.040 | |
itgb3b | integrin beta 3b | 0.040 | |
hoxb2a | homeo box B2a | 0.039 | |
ptgs1 | prostaglandin-endoperoxide synthase 1 | 0.039 | |
unc5b | unc-5 homolog B (C. elegans) | 0.039 | |
jun | jun proto-oncogene | 0.038 | |
cpb1 | carboxypeptidase B1 (tissue) | 0.038 | |
antxr1 | anthrax toxin receptor 1 | 0.038 | |
sulf1 | sulfatase 1 | 0.038 | |
epas1b | endothelial PAS domain protein 1b | 0.038 | |
esama | endothelial cell adhesion molecule a | 0.038 | |
ptprf | protein tyrosine phosphatase, receptor type, F | 0.037 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
Efnb2 | ephrin B2 | 0.987 | |
Wt1 | Wilms tumor 1 homolog | 0.952 | |
Epha4 | Eph receptor A4 | 0.934 | |
Kdr | kinase insert domain protein receptor | 0.921 | |
Nos2 | nitric oxide synthase 2, inducible | 0.904 | |
Csf1 | colony stimulating factor 1 (macrophage) | 0.894 | |
Smad6 | MAD homolog 6 (Drosophila) | 0.893 | |
Cxcl12 | chemokine (C-X-C motif) ligand 12 | 0.877 | |
Pdgfra | platelet derived growth factor receptor, alpha polypeptide | 0.862 | |
Smad3 | MAD homolog 3 (Drosophila) | 0.845 | |
Apc | adenomatosis polyposis coli | 0.845 | |
Ccr2 | chemokine (C-C motif) receptor 2 | 0.843 | |
Jag1 | jagged 1 | 0.841 | |
Gata6 | GATA binding protein 6 | 0.838 | |
Cxcl13 | chemokine (C-X-C motif) ligand 13 | 0.826 | |
Flt4 | FMS-like tyrosine kinase 4 | 0.816 | |
Ptgs2 | prostaglandin-endoperoxide synthase 2 | 0.803 | |
Flt1 | FMS-like tyrosine kinase 1 | 0.783 | |
Gata4 | GATA binding protein 4 | 0.770 | |
Nog | noggin | 0.769 | |
Gli3 | GLI-Kruppel family member GLI3 | 0.767 | |
Acvrl1 | activin A receptor, type II-like 1 | 0.704 | |
Npr3 | natriuretic peptide receptor 3 | 0.701 | |
Kras | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 0.699 | |
Sema6a | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | 0.693 | |
Bmp5 | bone morphogenetic protein 5 | 0.693 | |
Ephb2 | Eph receptor B2 | 0.650 | |
Lox | lysyl oxidase | 0.621 | |
Pax2 | paired box gene 2 | 0.612 | |
Clock | circadian locomotor output cycles kaput | 0.610 | |
Snai1 | snail homolog 1 (Drosophila) | 0.594 | |
Eng | endoglin | 0.593 | |
Sox7 | SRY-box containing gene 7 | 0.582 | |
Ccl2 | chemokine (C-C motif) ligand 2 | 0.557 | |
Tgfb2 | transforming growth factor, beta 2 | 0.555 | |
Fcer1g | Fc receptor, IgE, high affinity I, gamma polypeptide | 0.552 | |
Epha3 | Eph receptor A3 | 0.552 | |
Col4a2 | collagen, type IV, alpha 2 | 0.546 | |
Hey2 | hairy/enhancer-of-split related with YRPW motif 2 | 0.532 | |
Ntf3 | neurotrophin 3 | 0.524 | |
Foxf2 | forkhead box F2 | 0.522 | |
Adra2b | adrenergic receptor, alpha 2b | 0.509 | |
Ikzf1 | IKAROS family zinc finger 1 | 0.506 | |
Vegfa | vascular endothelial growth factor A | 0.504 | |
Fzd1 | frizzled homolog 1 (Drosophila) | 0.501 | |
Tcf21 | transcription factor 21 | 0.492 | |
Bmpr1a | bone morphogenetic protein receptor, type 1A | 0.491 | |
Selp | selectin, platelet | 0.491 | |
Emx1 | empty spiracles homolog 1 (Drosophila) | 0.487 | |
Id3 | inhibitor of DNA binding 3 | 0.469 | |
Foxg1 | forkhead box G1 | 0.462 | |
Arhgef11 | Rho guanine nucleotide exchange factor (GEF) 11 | 0.461 | |
Fgf8 | fibroblast growth factor 8 | 0.461 | |
Rag1 | recombination activating gene 1 | 0.460 | |
Pcdh12 | protocadherin 12 | 0.444 | |
Pgr | progesterone receptor | 0.441 | |
Cfh | complement component factor h | 0.436 | |
Arntl | aryl hydrocarbon receptor nuclear translocator-like | 0.435 | |
Lepr | leptin receptor | 0.433 | |
C3ar1 | complement component 3a receptor 1 | 0.432 | |
Twist2 | twist homolog 2 (Drosophila) | 0.432 | |
Tie1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.429 | |
Nr5a1 | nuclear receptor subfamily 5, group A, member 1 | 0.423 | |
Id1 | inhibitor of DNA binding 1 | 0.421 | |
Tcf3 | transcription factor 3 | 0.418 | |
Hoxd13 | homeobox D13 | 0.418 | |
Skil | SKI-like | 0.415 | |
Ccbp2 | chemokine binding protein 2 | 0.409 | |
Lhx1 | LIM homeobox protein 1 | 0.406 | |
Mfap2 | microfibrillar-associated protein 2 | 0.405 | |
Serpina3n | serine (or cysteine) peptidase inhibitor, clade A, member 3N | 0.400 | |
Adm | adrenomedullin | 0.399 | |
Il1b | interleukin 1 beta | 0.393 | |
Tlr4 | toll-like receptor 4 | 0.392 | |
Igk | immunoglobulin kappa chain complex | 0.391 | |
Foxc1 | forkhead box C1 | 0.390 | |
Hes1 | hairy and enhancer of split 1 (Drosophila) | 0.389 | |
Tgfbr2 | transforming growth factor, beta receptor II | 0.384 | |
Epas1 | endothelial PAS domain protein 1 | 0.380 | |
Folr2 | folate receptor 2 (fetal) | 0.380 | |
Fgfr2 | fibroblast growth factor receptor 2 | 0.377 | |
Sox3 | SRY-box containing gene 3 | 0.370 | |
Prl8a2 | prolactin family 8, subfamily a, member 2 | 0.366 | |
Itgb1 | integrin beta 1 (fibronectin receptor beta) | 0.359 | |
Emx2 | empty spiracles homolog 2 (Drosophila) | 0.350 | |
Cdh5 | cadherin 5 | 0.344 | |
Ncor2 | nuclear receptor co-repressor 2 | 0.343 | |
Tgfb1 | transforming growth factor, beta 1 | 0.340 | |
Ghr | growth hormone receptor | 0.336 | |
Gpc3 | glypican 3 | 0.333 | |
Dab2 | disabled homolog 2 (Drosophila) | 0.330 | |
Cd7 | CD7 antigen | 0.327 | |
Mitf | microphthalmia-associated transcription factor | 0.324 | |
Smad4 | MAD homolog 4 (Drosophila) | 0.324 | |
Src | Rous sarcoma oncogene | 0.318 | |
Ccr8 | chemokine (C-C motif) receptor 8 | 0.316 | |
Myod1 | myogenic differentiation 1 | 0.314 | |
Gdnf | glial cell line derived neurotrophic factor | 0.312 | |
Ntrk2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.308 | |
Aldh1a2 | aldehyde dehydrogenase family 1, subfamily A2 | 0.303 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
Egr2 | early growth response 2 | 0.661 | |
Ccl2 | chemokine (C-C motif) ligand 2 | 0.563 | |
Mdfic | MyoD family inhibitor domain containing | 0.509 | |
Mmp3 | matrix metallopeptidase 3 | 0.484 | |
Csf1 | colony stimulating factor 1 (macrophage) | 0.375 | |
Fgfr2 | fibroblast growth factor receptor 2 | 0.356 | |
Ccr2 | chemokine (C-C motif) receptor 2 | 0.324 | |
Hpx | hemopexin | 0.321 | |
Adora2a | adenosine A2a receptor | 0.302 | |
Reg1a | regenerating islet-derived 1 alpha | 0.240 | |
Fosl1 | fos-like antigen 1 | 0.213 | |
Tacr1 | tachykinin receptor 1 | 0.211 | |
Smgb | neonatal submandibular gland protein B | 0.209 | |
Iapp | islet amyloid polypeptide | 0.199 | |
Il1rn | interleukin 1 receptor antagonist | 0.195 | |
Il8rb | interleukin 8 receptor, beta | 0.190 | |
Il6 | interleukin 6 | 0.180 | |
Gucy2d | guanylate cyclase 2d | 0.179 | |
Stip1 | stress-induced phosphoprotein 1 | 0.174 | |
Nos3 | nitric oxide synthase 3, endothelial cell | 0.171 | |
Ccr5 | chemokine (C-C motif) receptor 5 | 0.169 | |
A1i3 | alpha-1-inhibitor III | 0.166 | |
Flt1 | FMS-related tyrosine kinase 1 | 0.164 | |
Ccl3 | chemokine (C-C motif) ligand 3 | 0.163 | |
Tpsab1 | tryptase alpha/beta 1 | 0.163 | |
Cxcl1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.160 | |
Cd151 | CD151 molecule (Raph blood group) | 0.158 | |
Cd4 | Cd4 molecule | 0.157 | |
Gzmk | granzyme K | 0.155 | |
Map3k8 | mitogen-activated protein kinase kinase kinase 8 | 0.155 | |
Cd200r1 | CD200 receptor 1 | 0.153 | |
Ms4a2 | membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide) | 0.153 | |
Il9r | interleukin 9 receptor | 0.151 | |
Met | met proto-oncogene | 0.150 | |
Id3 | inhibitor of DNA binding 3 | 0.146 | |
Eln | elastin | 0.132 | |
Asgr2 | asialoglycoprotein receptor 2 | 0.131 | |
Tas2r126 | taste receptor, type 2, member 126 | 0.131 | |
Ngf | nerve growth factor (beta polypeptide) | 0.128 | |
Anxa1 | annexin A1 | 0.126 | |
Cxcl2 | chemokine (C-X-C motif) ligand 2 | 0.121 | |
Trim47 | tripartite motif-containing 47 | 0.120 | |
Dusp1 | dual specificity phosphatase 1 | 0.117 | |
St8sia4 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 | 0.116 | |
LOC100361571 | keratin associated protein 1-3-like | 0.109 | |
Mmp10 | matrix metallopeptidase 10 | 0.107 | |
Emcn | endomucin | 0.106 | |
Gper | G protein-coupled estrogen receptor 1 | 0.106 | |
Ctsl1 | cathepsin L1 | 0.103 | |
Ccl11 | chemokine (C-C motif) ligand 11 | 0.103 | |
Il7 | interleukin 7 | 0.100 | |
Csf2rb | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.099 | |
LOC100363783 | rCG53773-like | 0.098 | |
Cpa3 | carboxypeptidase A3, mast cell | 0.098 | |
Mmp9 | matrix metallopeptidase 9 | 0.098 | |
Prok2 | prokineticin 2 | 0.097 | |
Il1b | interleukin 1 beta | 0.096 | |
Dusp6 | dual specificity phosphatase 6 | 0.094 | |
LOC60591 | calcium-activated potassium channel beta subunit | 0.094 | |
Prkch | protein kinase C, eta | 0.091 | |
Hoxa2 | homeo box A2 | 0.091 | |
Acvrl1 | activin A receptor type II-like 1 | 0.091 | |
Itgam | integrin, alpha M | 0.090 | |
Phyhd1 | phytanoyl-CoA dioxygenase domain containing 1 | 0.087 | |
Ccl4 | chemokine (C-C motif) ligand 4 | 0.086 | |
Adora3 | adenosine A3 receptor | 0.086 | |
Tpc1808 | tropic 1808 | 0.086 | |
Slc6a3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 0.085 | |
Calcrl | calcitonin receptor-like | 0.082 | |
Anxa4 | annexin A4 | 0.082 | |
Hspa5 | heat shock protein 5 | 0.081 | |
Sell | selectin L | 0.079 | |
Chordc1 | cysteine and histidine-rich domain (CHORD)-containing 1 | 0.078 | |
Serpina1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0.077 | |
Fos | FBJ osteosarcoma oncogene | 0.076 | |
Adam7 | ADAM metallopeptidase domain 7 | 0.076 | |
Crhr2 | corticotropin releasing hormone receptor 2 | 0.074 | |
Cd80 | Cd80 molecule | 0.074 | |
Nmbr | neuromedin B receptor | 0.073 | |
Ctla4 | cytotoxic T-lymphocyte-associated protein 4 | 0.073 | |
Plau | plasminogen activator, urokinase | 0.071 | |
Pmfbp1 | polyamine modulated factor 1 binding protein 1 | 0.071 | |
Ptpre | protein tyrosine phosphatase, receptor type, E | 0.070 | |
Mmp2 | matrix metallopeptidase 2 | 0.069 | |
Pou3f2 | POU class 3 homeobox 2 | 0.068 | |
Serpine1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.068 | |
Akr1c18 | aldo-keto reductase family 1, member C18 | 0.067 | |
Kcnmb1 | potassium large conductance calcium-activated channel, subfamily M, beta member 1 | 0.067 | |
Pemt | phosphatidylethanolamine N-methyltransferase | 0.067 | |
Slc6a12 | solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 | 0.066 | |
Bst1 | bone marrow stromal cell antigen 1 | 0.065 | |
Cd8a | CD8a molecule | 0.064 | |
Fgf2 | fibroblast growth factor 2 | 0.063 | |
Serpina11 | serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 | 0.063 | |
Junb | jun B proto-oncogene | 0.063 | |
LOC100364854 | similar to RIKEN cDNA A430107P09 gene-like | 0.063 | |
Crisp1 | cysteine-rich secretory protein 1 | 0.062 | |
Il2ra | interleukin 2 receptor, alpha | 0.062 | |
Vip | vasoactive intestinal peptide | 0.062 | |
Egfl7 | EGF-like-domain, multiple 7 | 0.061 |